Search

Author/Creator El Gaaloul, Myriam

1. Application of PBPK modeling to evaluate pharmacokinetic drug-drug interactions during the development of new antimalarial combination therapies. Issue 1 (January 2019)

Authors:
Abla, Nada; Almond, Lisa; Dickins, Maurice; Gobeau, Nathalie; Charman, Susan A.; Rowland-Yeo, Karen; El Gaaloul, Myriam; Barter, Zoe; Moehrle, Joerg; Wesche, David; Burrows, Jeremy
Journal:
Drug metabolism and pharmacokinetics
Issue:
Volume 34:Issue 1(2019)Supplement
Page Start:
S68
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Concentration‐QT modelling of the novel DHFR inhibitor P218 in healthy male volunteers. Issue 1 (9th July 2021)

Authors:
Täubel, Jӧrg; Lorch, Ulrike; Ferber, Georg; Spencer, Christopher S.; Freier, Anne; Coates, Simon; El Gaaloul, Myriam; Donini, Cristina; Chughlay, Mohamed Farouk; Chalon, Stephan
Other Names:
Magavern Emma guestEditor.; Piasecki Jan guestEditor.; Cremers Serge guestEditor.; Cohen Adam guestEditor.
Journal:
British journal of clinical pharmacology
Issue:
Volume 88:Issue 1(2022)
Page Start:
128
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. First‐in‐human clinical trial to assess the safety, tolerability and pharmacokinetics of P218, a novel candidate for malaria chemoprotection. Issue 6 (12th February 2020)

Authors:
Chughlay, M. Farouk; Rossignol, Emilie; Donini, Cristina; El Gaaloul, Myriam; Lorch, Ulrike; Coates, Simon; Langdon, Grant; Hammond, Tim; Möhrle, Jörg; Chalon, Stephan
Journal:
British journal of clinical pharmacology
Issue:
Volume 86:Issue 6(2020)
Page Start:
1113
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗